These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 17873671

  • 1. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale.
    Levine SZ, Rabinowitz J.
    J Clin Psychopharmacol; 2007 Oct; 27(5):431-6. PubMed ID: 17873671
    [Abstract] [Full Text] [Related]

  • 2. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G, Noisette C, Legrand A, Delahousse J.
    Encephale; 1997 Oct; 23(1):10-8. PubMed ID: 9172962
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M, Loza B.
    Psychiatr Pol; 2004 Oct; 38(5):795-808. PubMed ID: 15523927
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.
    Nitsche I, Kallert TW.
    Psychopathology; 2007 Oct; 40(4):242-53. PubMed ID: 17440287
    [Abstract] [Full Text] [Related]

  • 12. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.
    Kathmandu Univ Med J (KUMJ); 2006 Oct; 4(2):152-60. PubMed ID: 18603890
    [Abstract] [Full Text] [Related]

  • 13. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
    Lindenmayer JP, Bossie CA, Kujawa M, Zhu Y, Canuso CM.
    Psychopathology; 2008 Oct; 41(4):264-70. PubMed ID: 18441528
    [Abstract] [Full Text] [Related]

  • 14. Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.
    Levine SZ, Rabinowitz J, Rizopoulos D.
    Psychiatry Res; 2011 Aug 15; 188(3):446-52. PubMed ID: 21463902
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
    Ruhrmann S, Kissling W, Lesch OM, Schmauss M, Seemann U, Philipp M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1012-22. PubMed ID: 17412473
    [Abstract] [Full Text] [Related]

  • 16. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH, Kim YK.
    Neuropsychobiology; 2009 Jun 30; 59(1):51-8. PubMed ID: 19270464
    [Abstract] [Full Text] [Related]

  • 17. Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.
    Nolan KA, Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome LL, McEvoy J, Lieberman JA.
    J Psychiatr Res; 2005 Jan 30; 39(1):109-15. PubMed ID: 15504429
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S.
    Hum Psychopharmacol; 2008 Mar 30; 23(2):79-86. PubMed ID: 17972359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.